Anondita Medicare IPO closes today; subscription rises 128x, GMP at 48%
Anondita Medicare IPO received bids for 443.5 million equity shares against 1.55 million shares on offer as of 01:15 PM on Tuesday
SI Reporter New Delhi Anondita Medicare IPO subscription status Day 3: The three-day subscription window to bid for the
initial public offering (IPO) of Anondita Healthcare is set to conclude on Tuesday, August 26, 2025. The ₹69.5 crore SME offering, which opened for subscription on Friday, August 22, has received a solid response from investors so far.
According to data from the National Stock Exchange (NSE),
Anondita Healthcare IPO received bids for 443.5 million equity shares against 1.55 million shares on offer as of 01:15 PM on Tuesday. This reflects an oversubscription of 128.84 times.
Among the individual categories, non-institutional investors (NIIs) placed the highest number of bids, oversubscribing their reserved portion by 264.84 times. This was followed by retail investors, who bid 159.67 times. The qualified institutional buyers' (QIB) quota was booked 16.8 times.
Anondita Medicare IPO GMP
Anondita Medicare IPO details
The public offering of Anondita Medicare comprises a fresh issue of 4.8 million equity shares and no offer for sale (OFS) component.
The IPO is priced in the range of ₹137-145 per share, with a lot size of 1,000 shares. Investors can bid for a minimum of 1,000 shares and in multiples thereof. A retail investor would need a minimum of ₹2,90,000 to bid for two lots at the upper-end price.
As the subscription window concludes today, the basis of allotment for Anondita IPO shares is likely to be finalised on Thursday, August 28, 2025. The successful allottees will receive the company's shares in their demat accounts by Friday, August 29, 2025. Anondita Medicare shares are slated to list on the NSE and BSE, tentatively on Monday, September 1, 2025.
Maashitla Securities is the registrar of the issue. Narnolia Financial Services is the sole book-running lead manager.
According to the red herring prospectus (RHP), the company plans to use the issue proceeds for purchasing equipment and machinery, working capital requirements and unidentified acquisitions. The remaining funds will be used for general corporate purposes.
*Subscribe to Business Standard digital and get complimentary access to The New York TimesSubscribeRenews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Complimentary Access to The New York Times

News, Games, Cooking, Audio, Wirecutter & The Athletic
Curated Newsletters

Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
Seamless Access Across All Devices